首页> 外文期刊>Lab on a chip >A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells
【24h】

A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells

机译:一种组合的微磁微流控装置,用于快速捕获和培养稀有循环肿瘤细胞

获取原文
获取原文并翻译 | 示例
           

摘要

Here we describe a combined microfluidic-micromagnetic cell separation device that has been developed to isolate, detect and culture circulating tumor cells (CTCs) from whole blood, and demonstrate its utility using blood from mammary cancer-bearing mice. The device was fabricated from polydimethylsiloxane and contains a microfluidic architecture with a main channel and redundant 'double collection' channel lined by two rows of dead-end side chambers for tumor cell collection. The microdevice design was optimized using computational simulation to determine dimensions, magnetic forces and flow rates for cell isolation using epithelial cell adhesion molecule (EpCAM) antibody-coated magnetic microbeads (2.8 urn diameter). Using this device, isolation efficiencies increased in a linear manner and reached efficiencies close to 90% when only 2 to 80 breast cancer cells were spiked into a small volume (1.0 mL) of blood taken from wild type mice. The high sensitivity visualization capabilities of the device also allowed detection of a single cell within one of its dead-end side chambers. When blood was removed from FVB C3(1)-SV40 T-antigen mammary tumor-bearing transgenic mice at different stages of tumor progression, cells isolated in the device using anti-EpCAM-beads and magnetically collected within the dead-end side chambers, also stained positive for pan-cytokeratin-FITC and DAPI, negative for CD45-PerCP, and expressed SV40 large T antigen, thus confirming their identity as CTCs. Using this isolation approach, we detected a time-dependent rise in the number of CTCs in blood of female transgenic mice, with a dramatic increase in the numbers of metastatic tumor cells appearing in the blood after 20 weeks when tumors transition to invasive carcinoma and exhibit increased growth of metastases in this model. Importantly, in contrast to previously described CTC isolation methods, breast tumor cells collected from a small volume of blood removed from a breast tumor-bearing animal remain viable and they can be easily removed from these devices and expanded in culture for additional analytical studies or potential drug sensitivity testing.
机译:在这里,我们描述了一种组合的微流-微磁细胞分离装置,该装置已经开发出来,可以从全血中分离,检测和培养循环的肿瘤细胞(CTC),并展示其使用来自荷乳癌小鼠血液的效用。该设备由聚二甲基硅氧烷制成,并包含微流体结构,该结构具有主通道和多余的“双收集”通道,两排死角侧腔室排成一列,用于收集肿瘤细胞。使用计算仿真对微设备设计进行了优化,以确定使用上皮细胞粘附分子(EpCAM)抗体涂层的磁性微珠(直径2.8 um)进行细胞分离的尺寸,磁力和流速。使用该装置,当仅将2至80个乳腺癌细胞掺入少量(1.0 mL)野生型小鼠血液中时,隔离效率以线性方式增加,达到接近90%的效率。该设备的高灵敏度可视化功能还允许检测其死角侧腔之一内的单个细胞。当在肿瘤进展的不同阶段从FVB C3(1)-SV40 T-抗原乳腺肿瘤转基因小鼠中抽血时,使用抗EpCAM磁珠在设备中分离出细胞,并通过磁性收集在死角侧腔中,也对泛细胞角蛋白FITC和DAPI染色阳性,对CD45-PerCP染色阴性,并表达SV40大T抗原,从而确认了它们作为CTC的身份。使用这种隔离方法,我们检测到雌性转基因小鼠血液中CTC的数量呈时间依赖性上升,当肿瘤转变为浸润性癌并表现出20周后,血液中转移性肿瘤细胞的数量急剧增加该模型中转移的增长增加。重要的是,与先前描述的CTC分离方法相反,从携带有乳腺肿瘤的动物身上少量采集的血液中收集到的乳腺肿瘤细胞仍然可以存活,可以很容易地从这些装置中取出它们,并在培养中进行扩展以用于其他分析研究或潜在的应用。药物敏感性测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号